Company intelligence / Profile preview

Aktivo Labs

Ownership: Private
Development stage: Commercial

Overview

The company’s flagship product, the Aktivo Score®, has been validated as a digital biomarker correlating daily activity/sleep data with long-term risks for chronic diseases. Their solutions are used by insurers, enterprises, and governments to drive measurable reductions in risks for cardiovascular disease, type 2 diabetes, and clinical depression over rolling periods of up to four months.

Therapeutic areas: OtherPsychiatryEndocrinologyCardiovascular
Modalities: Non-pharmacological therapydigital biomarker platformdigital coachingdigital mental wellness
Industry: Digital Health Medical Devices

Partnerships

Life & health insurers

Beyond the preview

Go deeper on Aktivo Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aktivo Labs.

Explore the full profile